SAFETY AND EFFICACY OF TOCILIZUMAB THERAPY IN CHILDREN WITH SYSTEMIC ONSET OF JUVENILE IDIOPATHIC ARTHRITIS

被引：0
|
作者：
Alexeeva, E. [1 ]
Denisova, R. [1 ]
Valiyeva, S. [1 ]
Bzarova, T. [1 ]
Isayeva, K. [1 ]
Sleptsova, T. [1 ]
Mitenko, E. [1 ]
机构：
[1] Sci Ctr ChildrenS Hlth, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2267
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 258
页数：1
相关论文
共 50 条
  • [11] Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Kishimoto, Tadamitsu
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 735 - 743
  • [12] Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
    Shumpei Yokota
    Takako Miyamae
    Tomoyuki Imagawa
    Shigeki Katakura
    Rumiko Kurosawa
    Masaaki Mori
    Clinical Reviews in Allergy & Immunology, 2005, 28 : 231 - 237
  • [13] Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
    Yokota, S
    Miyamae, T
    Imagawa, T
    Katakura, S
    Kurosawa, R
    Mori, M
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 28 (03) : 231 - 237
  • [14] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
    Ramanan, Athimalaipet V.
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Cuttica, Ruben J.
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Gamir-Gamir, Maria Luz
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Wimalasundera, Sunethra
    Mallalieu, Navita L.
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    RHEUMATOLOGY, 2019, 58
  • [15] 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
    S Yokota
    T Imagawa
    T Miyamae
    K Kasai
    M Mori
    N Nishimoto
    T Kishimoto
    Pediatric Rheumatology, 6 (Suppl 1)
  • [16] TOCILIZUMAB THERAPY IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. RUSSIAN EXPERIENCE
    Alekseeva, E.
    Denisova, R.
    Valieva, S.
    Bzarova, T.
    Isayeva, K.
    Sleptsova, T.
    Mitenko, E.
    Chistyakova, E.
    Fetisova, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 736 - 737
  • [17] EFFICACY AND SAFETY OF TOCILIZUMAB IN SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS - DATA OF THE BIKER REGISTRY
    Klein, Ariane
    Ganser, Gerd
    Trauzeddel, Ralf
    Minden, Kisten
    Rietschel, Christoph
    Kuemmerle-Deschner, Jasmin
    Horneff, Gerd
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 969 - 969
  • [18] Efficacy and safety of an early response-based tapering regimen of tocilizumab in children with systemic juvenile idiopathic arthritis
    Dey, Soumya
    Roy, Debaditya
    Sinhamahapatra, Pradyot
    Ghosh, Alakendu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (05)
  • [19] The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma
    Ristic Goran
    Djokic Dragutin
    Pasic Srdjan
    Pediatric Rheumatology, 9 (Suppl 1)
  • [20] EXPERIENCE WITH TOCILIZUMAB IN 29 PATIENTS WITH SYSTEMIC ONSET JUVENILE IDIOPATHIC ARTHRITIS
    Horneff, G.
    Onken, N.
    Hospach, A.
    Ganser, G.
    Huppertz, H. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 737 - 738
12345